Immutep (IMMP) EBIT Margin (2011 - 2017)

Immutep (IMMP) posted EBIT Margin of 315.56% for Q2 2017, down 129.74% on a QoQ basis from 137.35% in Q1 2017, and up 66884.0% year-over-year from N/an in Q2 2016.

Immutep (IMMP) EBIT Margin (2011 - 2017) Analysis & Trends

Immutep's EBIT Margin history runs 5 years deep, the most recent figure standing at 315.56% for Q2 2017.

  • Quarterly EBIT Margin rose 66884.0% year-over-year to 315.56% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 380.83% (down 37923.0% YoY) and the FY2025 annual result came in at 594.28%, down 34.0% from the prior year.
  • EBIT Margin was 315.56% for Q2 2017 at Immutep, down from 137.35% in the prior quarter.
  • Across five years, EBIT Margin topped out at 103.46% in Q2 2014 and bottomed at 984.4% in Q2 2016.
  • A 4-year average of 349.58% and a median of 226.45% in 2017 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2016 — EBIT Margin slumped 98440 bps — and 2017, when it soared 66884 bps.
  • Immutep's EBIT Margin stood at 103.46% in 2014, then tumbled by 100 bps to 0.0% in 2015, then tumbled by 203281741 bps to 984.4% in 2016, then surged by 68 bps to 315.56% in 2017.
  • Business Quant data shows IMMP's EBIT Margin at 315.56% in Q2 2017, 137.35% in Q1 2017, and 984.4% in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 16.51%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 17.83%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 30.35%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immutep 569.08 Mn 569.08 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2017 -315.56%
Mar 31, 2017 -137.35%
Jun 30, 2016 -984.40%
Mar 31, 2016 -763.62%
Jun 30, 2015 0.00%
Jun 30, 2014 103.46%
Jun 30, 2011 100.31%